Cipla acquires Inzpera to enhance pediatric portfolio
market hours1 source ↓written by the desknot a recommendation
- in Inzpera Healthsciences
- 100% stake
- Inzpera Healthsciences
- ₹110.65 crore
Cipla has acquired a 100% stake in Inzpera Healthsciences for ₹110.65 crore, marking its entry into the pediatric care segment. This strategic move aims to capitalize on the rising demand for specialized pediatric products in India. Inzpera focuses on gastrointestinal, respiratory, and nutritional wellness for children, aligning with Cipla's growth strategy.
Not investment advice. For informational purposes only.